Yarong Liu

Yarong Liu (刘雅容) is the founder of Weitao Biotech (微滔生物), a biotech startup focused on innovative in vivo CAR-T cell therapy R&D, and appears in Qiming Venture Partners' communications variously as the company's founder & CEO and as its chairman . The company raised an angel round of over 100 million yuan led by Qiming Venture Partners, announced in November 2025, with Liu thanking Qiming and the other participating investors at the time . By June 2026, she appeared as Weitao Biotech's chairman at Qiming's 17th RMB Fund Annual Meeting, joining the innovative-drug panel on how Chinese biotech participates in global innovation . Beyond these details, elsewhere's corpus does not carry further biographical material on her.